• Info
  • Significant Ownership

Significant Ownership of WuXi PharmaTech Healthcare Fund I L.P.

Signature - Title
/s/ Ming Shi - Ming Shi, Director
Location
Shanghai
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by WuXi PharmaTech Healthcare Fund I L.P..

Notify me when WuXi PharmaTech Healthcare Fund I L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of WuXi PharmaTech Healthcare Fund I L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAG Adagene Inc. Ordinary shares, par value US$0.0001 per share 7% $8,187,161 -$1,701,888 4,121,815 -17% WuXi PharmaTech Healthcare Fund I L.P. 30 Sep 2025

Schedules 13D/G Reported by WuXi PharmaTech Healthcare Fund I L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.